Register Login
Register to leave comments
  • News bot Aug. 10, 2026, 8:16 p.m.

    📋 USANA HEALTH SCIENCES, INC. (SANA) - Financial Results

    Filing Date: 2026-08-10

    Accepted: 2026-08-10 16:09:40

    Event Type: Financial Results

    Event Details:

    USANA HEALTH SCIENCES, INC. (SANA) Reports the reporting period Financial Results USANA HEALTH SCIENCES, INC. (SANA) announced its financial results for the period ending the reporting period. Key Financial Highlights:
    • Revenue: Not disclosed
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: 24017
      • “Our team is executing on our goals of beginning clinical studies soon for both SC451 in type 1 diabetes and SG293 in non
      • Hodgkin lymphoma,” said Steve Harr, President and Chief Executive Officer. “Proof of concept data for these programs, including the recent update for UP421 in The New England Journal of Medicine and for an SG293 surrogate at the ASGCT meeting, are encouraging. If all goes as we anticipate, we expect to gain valuable insight into the clinical profiles and potential of both SC451 and SG293 over the next 6
      • 9 months, and we look forward to sharing our progress.” Corporate Highlights Continued progress toward beginning clinical trials for SC451 and SG293

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2026 2025 Change ($) Change (%)
    Cash Equivalents Marketable Securities 22.11K 79.82K $-57.72K -72.30%
    Operating Expenses Loss From Operations 94.97K 114.03K $-19.06K -16.71%
    Operating Expenses Other Income Net 598.00 1.11K $-511.00 -46.08%
    Operating Expenses Net Loss 93.80K 110.84K $-17.05K -15.38%
    Operating Expenses Net Loss Per Share 0.39 0.39 $0.00 +0.00%
    Cash and Marketable Securities 138.38K 138.38K $0.00 +0.00%
    Loss from Operations 94.97K 114.03K $-19.06K -16.71%
    Interest Income 577.00 2.08K $-1.50K -72.26%
    Other Income, Net 598.00 1.11K $-511.00 -46.08%
    Net Loss 93.80K 110.84K $-17.05K -15.38%

    💼 Business Developments:

    • Partnership
    • Acquisition
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: USANA HEALTH SCIENCES, INC.
    • Ticker Symbol: SANA

Search

News categories